JVM Co

JVM Co Net Debt/Equity

The Net Debt to Equity Ratio of JVM Co (054950.KQ) as of Nov 4, 2026 is -0.37. In the previous year, Net Debt to Equity Ratio was -0.32 — a change of 15.43% (lower).

Net Debt/Equity

-0.37

YoY

15.43%

Last updated:

Net Debt to Equity Ratio of JVM Co is 2024 -0.37 . Net Debt to Equity Ratio of JVM Co was 2023 -0.32 . It decreases by 15.43% lower compared to the previous year.

The JVM Co Net Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/Equity
Date
Net Debt/Equity
Jan 1, 2017
0.07 KRW
Jan 1, 2018
0.00 KRW
Jan 1, 2019
-0.07 KRW
Jan 1, 2020
-0.09 KRW
Jan 1, 2021
-0.21 KRW
Jan 1, 2022
-0.23 KRW
Jan 1, 2023
-0.32 KRW
Jan 1, 2024
-0.37 KRW
The JVM Co Net Debt/Equity history
YEARNet Debt/EquityYoY
-0.37+15.43%
-0.32+39.58%
-0.23+10.03%
-0.21+121.39%
-0.09+43.10%
-0.07-1,934.28%
0.00-95.20%
0.07-41.69%
0.13+4.01%
0.12-74.43%
0.48—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Net Debt to Equity Ratio of JVM Co is -0.37 in 2024.

Net Debt to Equity Ratio of JVM Co changed from -0.32 to -0.37, representing a 15.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Equity Ratio JVM Co since 2006 – with annual values, charts, and detailed analysis.

Net Debt/Equity adjusts the debt-to-equity ratio by subtracting cash from total debt. It provides a more accurate picture of actual leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Equity Ratio's JVM Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — JVM Co

All Key Metrics — JVM Co